Venture Associate

Website Alloy-82VS

Alloy 82VS builds and invests in early stage biotechnology startups leveraging the tools and capabilities of the Alloy ecosystem. To date 82VS has founded nine asset-focused companies developing new medicines across the areas of oncology, immunology, ophthalmology, neurology, and rare diseases. Our current companies are developing antibody, antisense oligonucleotide, and TCR mimic therapeutics, but we are also working actively to build out multimodal therapeutics and expand our delivery capabilities (e.g., LNPs, peptides).

We are hiring Venture Associates who are recent graduates from doctoral programs and interested in learning about biotech company building and investing. Venture Associates at 82VS will be exposed to all aspects of new company building, including science, medicine, strategy, financing, operations, and legal. This is a full-time position targeting a start date of late summer/early fall 2022 in Waltham, MA. For more information on the 82VS team, see our webpage.

About Alloy-82VS

Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners, Alloy democratizes access to pre-competitive tools, technologies, services, and company creation capabilities that are foundational for discovering and developing therapeutic biologics. The company facilitates affordable, non-exclusive access to the entire drug discovery community from academic scientists, small and medium biotech, to the largest biopharma. Alloy is headquartered in Waltham, MA with labs in Cambridge, UK; Basel, CH; San Francisco, CA; and Athens, GA. As a reflection of Alloy’s relentless commitment to the scientific community, Alloy reinvests 100% of its revenue in innovation and access to innovation.

In 2020, Alloy launched 82VS, which builds and invests in early stage biotechnology startups leveraging the tools and capabilities of the Alloy ecosystem. To date 82VS has founded nine asset-focused companies developing new medicines across the areas of oncology, immunology, ophthalmology, neurology, and rare diseases. Our current companies are developing antibody, antisense oligonucleotide, and TCR mimic therapeutics, but we are also working actively to build out multimodal therapeutics and expand our delivery capabilities (e.g., LNPs, peptides).

At Alloy, we believe our industry should compete on getting the best drugs to patients as quickly as possible, not exclusive access to the best platforms. The team and company are rapidly expanding; successful members thrive in our shared culture of accountability, deliberate trust, and open communication. As a team we aspire to work together to exceed expectations and collectively contribute across the global organization to always maintain our nimble, startup culture.

To apply for this job please visit alloytherapeutics.applytojob.com.